3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Myelodysplastic Syndromes
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Hematologic Neoplasms
9
Myeloproliferative Disorders
8
Multiple Myeloma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
7
Lymphoma, Non-Hodgkin
6
Graft vs Host Disease
6
Waldenstrom Macroglobulinemia
5
Lymphoma
5
Burkitt Lymphoma
5
Recurrence
4
Primary Myelofibrosis
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma, Mantle-Cell
4
Leukemia, Prolymphocytic
4
Leukemia, Myelomonocytic, Chronic
4
Skin Neoplasms
3
Sarcoma
3
Rhabdomyosarcoma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Bronchiolitis Obliterans Syndrome
3
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Temozolomide
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Sirolimus
×
1 year
×
Clear all
No trials found.